http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2238079-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85046f5547cb42547fbf9569b15070cc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3486
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C02F1-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42
filingDate 2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ee3f33b9afc71b0040508f4036f075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_705d0abb22db7d4b0ece061d80ebc1b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65e6cf8cff10afcd5d717863df563148
publicationDate 2010-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2238079-A2
titleOfInvention Method and apparatus for increasing contaminant clearance rates during extracorporeal fluid treatment
abstract An extracorporeal fluid treatment apparatus includes a separator comprising a cartridge surrounding a porous separation membrane. The membrane separates a main flow path of a cellular component of the blood from a plasma flow path. An affinity medium is disposed within the plasma flow path to bind contaminants such as viral pathogens or toxins contained within the plasma. A pump pumps the plasma through the affinity medium at an assisted flow rate preferably between 10% and 40% of the whole blood flow rate. The assisted flow rate is selected to reduce a T90% of the apparatus by at least 50% as compared to a T90% of the apparatus without the plasma pump. A method of treating blood containing contaminants includes supplying infected blood to a separator and pumping the plasma component through an affinity medium at an assisted flow rate to increase contaminant clearance.
priorityDate 2007-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5418061-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004175291-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6627151-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5286449-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9172
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49357
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161658
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID64006
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID39639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405416
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID39639

Total number of triples: 29.